The Role of ACKR3 in Breast, Lung, and Brain Cancer.

Abstract:

:Recent reports regarding the significance of chemokine receptors in disease have put a spotlight on atypical chemokine receptor 3 (ACKR3). This atypical chemokine receptor is overexpressed in numerous cancer types and has been involved in the modulation of tumor cell proliferation and migration, tumor angiogenesis, or resistance to drugs, thus contributing to cancer progression and metastasis occurrence. Here, we focus on the clinical significance and potential mechanisms underlying the pathologic role of ACKR3 in breast, lung, and brain cancer and discuss its possible relevance as a prognostic factor and potential therapeutic target in these contexts.

journal_name

Mol Pharmacol

journal_title

Molecular pharmacology

authors

Neves M,Fumagalli A,van den Bor J,Marin P,Smit MJ,Mayor F

doi

10.1124/mol.118.115279

subject

Has Abstract

pub_date

2019-12-01 00:00:00

pages

819-825

issue

6

eissn

0026-895X

issn

1521-0111

pii

mol.118.115279

journal_volume

96

pub_type

杂志文章,评审